Previewing ASCO with J&J CEO Joaquin Duato cnbc.com/video/2025/05/…

NEW FROM STAT: The death of a second teenage boy from liver failure caused by a gene therapy from Sarepta $SRPT has left the #Duchenne community angry, fearful and divided over whether to maintain hope in the therapy. Essential new reporting on Elevidys and the consequences of

Inside CNBC's "Baby Boom": People If you don't see the inimitable Deirdre Bosa Kelly Evans Pippa Stevens Megan Cassella Angelica Peebles on the air this summer/ fall, now you know why! 🤰 people.com/inside-cnbc-s-…

FDA Commissioner Makary says yesterday's CRL dump was just the beginning and that FDA plans to post them in "real time" going forward cnbc.com/video/2025/07/…

With Verona deal, Merck wagers on strength of lung drug’s patents biopharmadive.com/news/merck-ver… via Jon Gardner $MRK $VRNA

In recent months, Hims has been the topic of fervid conversation, disdain and intrigue among any number of groups—pharma companies, short sellers, meme-stock investors, and, of course, those trying to find an affordable way to shed a few pounds. For Businessweek bloomberg.com/news/features/…

As Sarepta, FDA tangle over Duchenne therapy, families are caught in the middle, ⁦Jason Mast⁩ writes statnews.com/2025/07/24/duc…

I'm told this is the case from Brazil. Regulators there determined the boy likely died from flu intensified by immunosuppression fda.gov/news-events/pr…

Breaking down Lilly's Mounjaro cardiovascular outcomes trial Surpass-CVOT $LLY cnbc.com/video/2025/07/…

Took a step back to look at the different strategies Moderna and BioNTech have taken since finding success with their Covid-19 vaccines -- and the stark divergence in their stock prices cnbc.com/2025/07/31/cov…

Trump (once again) says pharma tariffs are coming in the next few weeks, will start low and increase over time cnbc.com/2025/08/05/tru…

50+ biotech startups secured $50M+ IPOs from Feb. 13 to Aug. 13 in 2021 There have been 0 in the same six-month stretch this year (in the US) endpoints.news/biotech-indust…

Fujifilm Biotechnologies' new U.S. biologics manufacturing facility opens in just a few weeks. It's taken five years and $3.2 billion to get here, an example of just how hard it is to stand up new pharma manufacturing cnbc.com/2025/08/21/fuj…

Lilly today is unveiling the details of the first of four new U.S. manufacturing facilities. Just last week, the company paused plans to build a biotech incubator in the U.K. More from Lilly CEO Dave Ricks on the global policy outlook: cnbc.com/2025/09/16/eli…

Our coverage of the ACIP's Covid-19 vaccine vote, which replaced specific recommendations with broad guidance that all people 6 months and older consult a health care provider before getting the vaccine. endpoints.news/acip-recommend…